Literature DB >> 10938890

Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies.

I A Hagberg1, T Lyberg.   

Abstract

A variety of flow cytometry techniques are in use to evaluate in vivo blood platelet activation. We have in this study further developed and optimised these methods to be suitable for use in clinical studies. By preloading the Monovette EDTA vacuum blood sampling tubes with 1/8 vol 4% (w/v) paraformaldehyde (PFA), we were able to assess platelet CD62P (P-selectin) expression in whole blood with less than 0.2% activated platelets. No washing or neutralising steps were required to remove excess fixative. Both basal and agonist-stimulated CD62P expression were stable for at least 48 h after sampling. The standard curve was linear from 1.9 (basal) to 8.1 x 10(3) (TRAP-stimulated) molecules of equivalent soluble fluorochrome units (MESF) in phycoerythrein-conjugated anti-CD62P labelled whole blood samples. These assay conditions were also well suited for assessment of platelet expression of CD41, CD42a, CD61 and CD63. The preanalytic storage period was extended from 10 min to at least 2 h for platelet PAC-1 and fibrinogen binding analysis by preloading Monovette citrate tubes with 8/10 vol buffer. With PFA preloading, blood sampled into citrated tubes could be analysed for fractions of microparticles and platelet-platelet aggregates as well as for aggregate size.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938890     DOI: 10.1080/095371000403071

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  10 in total

Review 1.  Biological effects of dynamic shear stress in cardiovascular pathologies and devices.

Authors:  Gaurav Girdhar; Danny Bluestein
Journal:  Expert Rev Med Devices       Date:  2008-03       Impact factor: 3.166

Review 2.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

3.  GPIbα reflects the development and progress of the patients with severe preeclampsia.

Authors:  Fu-Ju Wu; Ming-Yang Zheng; Lian-Lian Liu; Dan-Dan Wang; Xiao-Yan Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Cilostazol reduces PAC-1 expression on platelets in ischemic stroke.

Authors:  Su-Yun Lee; Myong-Jin Kang; Jae-Kwan Cha
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

5.  HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function.

Authors:  Maik Sossdorf; Sascha Marx; Barbara Schaarschmidt; Gordon P Otto; Ralf A Claus; Konrad Reinhart; Christiane S Hartog; Wolfgang Lösche
Journal:  Crit Care       Date:  2009-12-22       Impact factor: 9.097

6.  New horizons in platelets flow cytometry.

Authors:  Muhammad Saboor; Moinuddin Moinuddin; Samina Ilyas
Journal:  Malays J Med Sci       Date:  2013-03

7.  Impact of high mechanical shear stress and oxygenator membrane surface on blood damage relevant to thrombosis and bleeding in a pediatric ECMO circuit.

Authors:  Wenji Sun; Shigang Wang; Zengsheng Chen; Jiafeng Zhang; Tieluo Li; Katherin Arias; Bartley P Griffith; Zhongjun J Wu
Journal:  Artif Organs       Date:  2020-02-19       Impact factor: 3.094

8.  A whole blood model of thrombocytopenia that controls platelet count and hematocrit.

Authors:  R S Bercovitz; M K Brenner; D K Newman
Journal:  Ann Hematol       Date:  2016-08-12       Impact factor: 3.673

9.  Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor.

Authors:  Zengsheng Chen; Nandan K Mondal; Jun Ding; Steven C Koenig; Mark S Slaughter; Zhongjun J Wu
Journal:  Artif Organs       Date:  2015-11-18       Impact factor: 3.094

10.  Efficient removal of platelets from peripheral blood progenitor cell products using a novel micro-chip based acoustophoretic platform.

Authors:  Josefina Dykes; Andreas Lenshof; Ing-Britt Åstrand-Grundström; Thomas Laurell; Stefan Scheding
Journal:  PLoS One       Date:  2011-08-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.